obesity ;diabetes; glp-1 agonists; incretin

In this episode, hosts discuss the efficacy of MariTide for obesity, a head-to-head comparison of semaglutide vs. tirzepatide, and concerns about GLP-1 agonist compounding. https://www.hcplive.com/view/diabetes-dialogue-exploring-new-horizons-in-incretin-therapy-for-diabetes-and-weight-loss...